Effects of depression screening on diagnosing and treating mood disorders among older adults in office-based primary care outpatient settings: An instrumental variable analysis

Preventive Medicine

Volumn 100, Issue , 2017, Pages 101-111

  Rhee, Taeho Greg ^a   Capistrant, Benjamin D ^b   Schommer, Jon C ^a   Hadsall, Ronald S ^a   Uden, Donald L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aged; Antidepressant; Depression; Depression screening; Mood disorders; Primary care

Indexed keywords

ANTIDEPRESSANT AGENT;

ACCIDENT PREVENTION; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DEPRESSION ASSESSMENT; ELDERLY CARE; FEMALE; HEALTH CARE SURVEY; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOME ASSESSMENT; OUTPATIENT CARE; PHYSICIAN ATTITUDE; POPULATION RESEARCH; POTENTIALLY INAPPROPRIATE MEDICATION; PRESCRIPTION; PRIMARY HEALTH CARE; STRESS MANAGEMENT; MASS SCREENING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MASS SCREENING; MOOD DISORDERS; PRIMARY HEALTH CARE;

EID: 85018512930     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2017.04.015     Document Type: Article

References (54)

1. Akincigil, A., Matthews, E., National Rates and Patterns of Depression Screening in Primary Care: Implications for Social Work Involvement in Primary Health Care Settings. Paper Presented at: Society for Social Work and Research. 2016 (Washington, D.C.).
2. American Geriatrics Society Beers Criteria Update Expert Panel, American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 60:4 (2012), 616–631.
3. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society, Updated beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc., 2015, 2015.
4. American Society of Health-System Pharmacists, American Hospital Formulary Service (AHFS) Drug Information. 2015, American Society of Health-System Pharmacists, Bethesda, MD.
5. Aparasu, R.R., Jano, E., Bhatara, V., Concomitant antipsychotic prescribing in US outpatient settings. Res. Social Adm. Pharm. 5:3 (2009), 234–241.
6. Beers, M.H., Ouslander, J.G., Rollingher, I., Reuben, D.B., Brooks, J., Beck, J.C., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch. Intern. Med. 151:9 (1991), 1825–1832.
7. Budnitz, D.S., Lovegrove, M.C., Shehab, N., Richards, C.L., Emergency hospitalizations for adverse drug events in older Americans. N. Engl. J. Med. 365:21 (2011), 2002–2012.
8. Cahir, C., Bennett, K., Teljeur, C., Fahey, T., Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br. J. Clin. Pharmacol. 77:1 (2014), 201–210.
9. Comer, J.S., Mojtabai, R., Olfson, M., National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am. J. Psychiatry 168:10 (2011), 1057–1065.
10. Daumit, G.L., Pratt, L.A., Crum, R.M., Powe, N.R., Ford, D.E., Characteristics of primary care visits for individuals with severe mental illness in a national sample. Gen. Hosp. Psychiatry 24:6 (2002), 391–395.
11. Fick, D.M., Waller, J.L., Maclean, J.R., et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J. Manag. Care Pharm. 7:5 (2001), 407–413.
12. Finkelstein, E., Prabhu, M., Chen, H., Increased prevalence of falls among elderly individuals with mental health and substance abuse conditions. Am. J. Geriatr. Psychiatry 15:7 (2007), 611–619.
13. Fu, A.Z., Jiang, J.Z., Reeves, J.H., Fincham, J.E., Liu, G.G., Perri, M. 3rd., Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med. Care 45:5 (2007), 472–476.
14. Harrison, D.L., Miller, M.J., Schmitt, M.R., Touchet, B.K., Variations in the probability of depression screening at community-based physician practice visits. Prim. Care Companion J. Clin. Psychiatry, 12(5), 2010.
15. Jameson, J.P., Blank, M.B., Diagnosis and treatment of depression and anxiety in rural and nonrural primary care: national survey results. Psychiatr. Serv. 61:6 (2010), 624–627.
16. Khandker, S.R., Koolwal, G.B., Samad, H.A., Handbook on Impact Evaluation: Quantitative Methods and Practices. 2010, Washington, D.C., World Bank.
17. Klarin, I., Wimo, A., Fastbom, J., The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22:1 (2005), 69–82.
18. Klungel, O.H., Jamal Uddin, M., de Boer, A., Belitser, S.V., Groenwold, R.H., Roes, K.C., Instrumental variable analysis in epidemiologic studies: an overview of the estimation methods. Pharm. Anal. Acta 6:4 (2015), 1–9.
19. Lagomasino, I.T., Stockdale, S.E., Miranda, J., Racial-ethnic composition of provider practices and disparities in treatment of depression and anxiety, 2003–2007. Psychiatr. Serv. 62:9 (2011), 1019–1025.
20. Lau, D.T., Kasper, J.D., Potter, D.E., Lyles, A., Bennett, R.G., Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch. Intern. Med. 165:1 (2005), 68–74.
21. Lindley, C.M., Tully, M.P., Paramsothy, V., Tallis, R.C., Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21:4 (1992), 294–300.
22. Lindsey, P.L., Psychotropic medication use among older adults: what all nurses need to know. J. Gerontol. Nurs. 35:9 (2009), 28–38.
23. Mamdani, M.M., Parikh, S.V., Austin, P.C., Upshur, R.E., Use of antidepressants among elderly subjects: trends and contributing factors. Am. J. Psychiatry 157:3 (2000), 360–367.
24. Mander, A., Clayton, D., HOTDECK: Stata Module to Impute Missing Values Using the Hotdeck Method. 2007, Boston College Department of Economics.
25. Manseau, M., Case, B.G., Racial-ethnic disparities in outpatient mental health visits to U.S. physicians, 1993–2008. Psychiatr. Serv. 65:1 (2014), 59–67.
26. Maust, D.T., Oslin, D.W., Marcus, S.C., Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey. J. Am. Geriatr. Soc. 62:2 (2014), 358–364.
27. Miller, G.E., Sarpong, E.M., Davidoff, A.J., Yang, E.Y., Brandt, N.J., Fick, D.M., Determinants of potentially inappropriate medication use among community-dwelling older adults. Health Serv. Res., 2016.
28. Mojtabai, R., Does depression screening have an effect on the diagnosis and treatment of mood disorders in general medical settings?: an instrumental variable analysis of the national ambulatory medical care survey. Med. Care Res. Rev. 68:4 (2011), 462–489.
29. Mojtabai, R., Olfson, M., National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch. Gen. Psychiatry 67:1 (2010), 26–36.
30. Mort, J.R., Aparasu, R.R., Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch. Intern. Med. 160:18 (2000), 2825–2831.
31. National Center for Health Statistics, NAMCS Micro-data File Documentation. 2010, 2010.
32. National Center for Health Statistics, About the ambulatory health care surveys. http://www.cdc.gov/nchs/ahcd/about_ahcd.htm, 2012 (2015).
33. National Center for Health Statistics, Ambulatory health care data: questionnaires, datasets, and related documentation. http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm, 2015.
34. O'Connor, E.A., Whitlock, E.P., Beil, T.L., Gaynes, B.N., Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann. Intern. Med. 151:11 (2009), 793–803.
35. Olfson, M., Marcus, S.C., National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66:8 (2009), 848–856.
36. Olfson, M., Blanco, C., Marcus, S.C., Treatment of adult depression in the United States. JAMA Intern. Med. 176:10 (2016), 1482–1491.
37. Palmer, S.C., Coyne, J.C., Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J. Psychosom. Res. 54:4 (2003), 279–287.
38. Pignone, M.P., Gaynes, B.N., Rushton, J.L., et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 136:10 (2002), 765–776.
39. Rhee, T.G., Capistrant, B.D., Schommer, J.C., et al. Impact of the 2009 USPSTF depression screening recommendation on diagnoising and treating mood disorders: a difference-in-differences analysis. Health Serv. Res., 2017 (revised and resubmitted).
40. Rhee, T.G., Schommer, J.C., Capistrant, B.D., et al. Potentially inappropriate antidepressant use among older adults in office-based outpatient settings: national trends from 2002 to 2012. Adm. Policy Ment. Health Ment. Health Serv. Res., 2017 (under blinded reivew).
41. Sankaranarayanan, J., Puumala, S.E., Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996–2003: national estimates and associated factors. Clin. Ther. 29:4 (2007), 723–741.
42. Schmader, K.E., Hanlon, J.T., Landsman, P.B., Samsa, G.P., Lewis, I.K., Weinberger, M., Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann. Pharmacother. 31:5 (1997), 529–533.
43. Sclar, D.A., Robison, L.M., Schmidt, J.M., Bowen, K.A., Castillo, L.V., Oganov, A.M., Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?. Clin. Drug Investig. 32:2 (2012), 139–144.
44. Siu, A.L., Force, U.S.P.S.T., Bibbins-Domingo, K., et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA 315:4 (2016), 380–387.
45. Stata Statistical Software: Release 13 [Computer Program]. 2013, StataCorp LP, College Station, TX.
46. Thombs, B.D., Ziegelstein, R.C., Does depression screening improve depression outcomes in primary care?. BMJ, 348, 2014, g1253.
47. Thombs, B.D., Coyne, J.C., Cuijpers, P., et al. Rethinking recommendations for screening for depression in primary care. CMAJ 184:4 (2012), 413–418.
48. Thombs, B.D., Ziegelstein, R.C., Roseman, M., Kloda, L.A., Ioannidis, J.P., There are no randomized controlled trials that support the United States preventive services task force guideline on screening for depression in primary care: a systematic review. BMC Med., 12, 2014, 13.
49. U. S. Preventive Services Task Force, Screening for depression: recommendations and rationale. Ann. Intern. Med. 136:10 (2002), 760–764.
50. U. S. Preventive Services Task Force, Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 151:11 (2009), 784–792.
51. U.S. Preventive Services Task Force, Final recommendation statement: depression in adults–screening. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/depression-in-adults-screening1, 2016 (2016).
52. United States Census Bureau, Geographic Areas Reference Manual (GARM). 2017 (https://www.census.gov/geo/reference/garm.html. Accessed Feb. 13, 2017).
53. Wolters Kluwer Clinical Drug Information, Facts and comparisons. http://www.wolterskluwercdi.com/, 2015 (Accessed July 16, 2015).
54. Zuckerman, I.H., Langenberg, P., Baumgarten, M., et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med. Care 44:8 (2006), 722–730.